Tuesday, 31 May 2011

Diabetes Drug Actos Linked to Bladder Cancer

An analysis of the Food and Drug Administration database indicates that people who take the anti-type II diabetes drug Actos may be at a higher risk of suffering bladder cancer.

According to the analysis, between 2004 and 2009, more than 500,000 adverse reactions were recorded among people who took the anti-diabetes drug. Out of these reports, there were at least 138 instances of bladder cancer. However, more than 1/5th of the cancer patients were on Actos. This suggests that patients who take Actos to contain their diabetes may have a disproportionately high risk of developing bladder cancer, compared to patients who take one of the other 15 different anti-diabetes drugs.

However, the researchers caution against reading too much into the study. Persons who are on certain medications may develop conditions as a result of the medication, but that does not necessarily mean that they are at a high risk of that condition. In other words, the statistics are not an authoritative indicator that Actos increases the risk of bladder cancer among users. However, the analysis does indicate the need for further research. While there is no confirmed link between an increased risk of bladder cancer and Actos, the disproportionate risk of developing cancer indicates a possible risk.

The Food and Drug Administration has been aware of this possible risk of developing cancer from Actos for a while now. Last year, the agency began a review of the drug after it received results from a study conducted by the manufacturer of Actos, Takeda Pharmaceutical Company Limited. The manufacturer’s study indicated that patients with the longest exposure to Actos, and those with who took cumulative dosages of the drug had an increased risk of developing bladder cancer.

California pharmaceutical liability attorneys would advise patients on Actos not to stop taking the medicine immediately. Instead, consult with your doctor to evaluate the risks of taking the medication, compared to the benefits before making a decision.

1 comment:

  1. Are you serious this doesnt seem like a safe drug